ReviewFrontiers in psychiatry2026
Advances in implementation strategies for treatment adherence in schizophrenia: a narrative review.
Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- AI-powered cognitive remediation for schizophrenia: a psychologist's lens on evidence and scalability in India.Frontiers in psychology · 2026Pooled it
- Perception and willingness toward second-generation long-acting antipsychotics among patients with schizophrenia: a cross-sectional survey in Fujian, China.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia is a chronic, relapsing mental illness where poor treatment adherence is a core challenge, significantly contributing to relapse and poor prognosis. Despite the efficacy of current pharmacotherapy, non-adherence rates are high. This review synthesizes the latest research on intervention strategies for improving treatment adherence in schizophrenia, exploring the effectiveness, limitations, and future directions of various approaches. We delve into behavioral and psychological interventions (including patient education, CBT, and motivational interviewing), pharmacological strategies (such as long-acting injectables), digital health technologies (like mobile apps, telemedicine, and wearable devices), and comprehensive, multidisciplinary care models. While each strategy demonstrates potential, they face challenges including a lack of standardized assessment tools, resource limitations, and the need for long-term efficacy data. Current research indicates a shift towards integrated and personalized interventions. We conclude that future efforts should focus on combining these diverse strategies into a holistic, patient-centered model, leveraging emerging technologies like AI and big data to provide more effective and sustainable support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.